Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 18 June 2009, Vol. 113, No. 25, pp. 6372-6381.
Prepublished online as a Blood First Edition Paper on April 7, 2009; DOI 10.1182/blood-2008-08-175828.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Table and Figure
Right arrow All Versions of this Article:
blood-2008-08-175828v1
113/25/6372    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaganti, S.
Right arrow Articles by Bell, A. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chaganti, S.
Right arrow Articles by Bell, A. I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted August 26, 2008
Accepted March 16, 2009

Epstein-Barr virus colonisation of tonsillar and peripheral blood B cell subsets in primary infection and persistence

Sridhar Chaganti, Emily M Heath, Wolfgang Bergler, Michael Kuo, Maike Buettner, Gerald Niedobitek, Alan B. Rickinson*, and Andrew I. Bell

Cancer Research UK Institute for Cancer Studies, University of Birmingham, Birmingham, United Kingdom
Krankenhaus St. Joseph-Stift Bremen, Bremen, Germany
Birmingham Children's Hospital, Birmingham, United Kingdom
Pathological Institute, University Hospital Erlangen, Erlangen, Germany
Institute for Pathology, Sana Klinikum Lichtenberg/Unfallkrankenhaus Berlin, Berlin, Germany

* Corresponding author; email: a.b.rickinson{at}bham.ac.uk.

Epstein-Barr virus (EBV) persists in the immune host by preferentially colonising the isotype-switched (IgD- CD27+) memory B cell pool. In one scenario, this is achieved through virus infection of naive (IgD+ CD27-) B cells and their differentiation into memory via germinal centre (GC) transit; in another, EBV avoids GC transit and infects memory B cells directly. We report two findings consistent with this latter view. Firstly we examined circulating non-isotype-switched (IgD+ CD27+) memory cells, a population which much evidence suggests is GC-independent in origin. While isotype-switched memory had the highest viral loads by Q-PCR, EBV was detectable in the non-switched memory pool both in infectious mononucleosis (IM) patients undergoing primary infection and in most long-term virus carriers. Secondly we examined EBV's colonisation of B cell subsets sorted from a unique collection of IM tonsillar cell suspensions. Here viral loads were concentrated in B cells with the CD38 marker of GC origin, but lacking other GC markers CD10 and CD77. These findings, supported by histologic evidence, suggest that EBV infection in IM tonsils involves extra-follicular B cells expressing CD38 as an activation antigen and not as a marker of ectopic GC activity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020